[This week's review was originally posted at the Nieman Journalism Lab Purchase Bactrim, on May 20, 2011.]
Twitter on the brain: Last week, New York Times executive editor Bill Keller got a rise out of a lot of folks online with one of the shortest of his 21 career tweets: "#TwitterMakesYouStupid. Discuss." Keller revealed the purpose of his social experiment this week in a column arguing, in so many words, that Twitter may be dulling your humanity, and probably making you stupid, too. Here's the money quote: "my inner worrywart wonders whether the new technologies overtaking us may be eroding characteristics that are essentially human: our ability to reflect, real brand Bactrim online, our pursuit of meaning, genuine empathy, a sense of community connected by something deeper than snark or political affinity."
This, as you might imagine, did not go over particularly well online. Bactrim used for, There were a couple strains of reaction: Business Insider's Henry Blodget and All Twitter's Lauren Dugan argued that Twitter may indeed be changing us, but for the good, by helping make previously impossible connections.
Alexia Tsotsis of TechCrunch and Mike Masnick of Techdirt countered Keller by saying that while Twitter isn't built for deep conversations, it is quite good at providing an entry point for such discussion: "What you see publicly posted on Twitter and Facebook is just the tip of the conversation iceberg," Tsotsis said. GigaOM's Mathew Ingram, meanwhile, defended Twitter's true social nature, and sociologist Zeynep Tufekci gave a fantastic breakdown of what Twitter does and doesn't do culturally and socially, Purchase Bactrim.
Two of the most eloquent responses were provided by Nick Bilton, Bactrim brand name, one of Keller's own employees, and by Gizmodo's Mat Honan. Bilton pointed out that our brains have shown a remarkable ability to adapt quickly to new technologies without sacrificing old capacities. (Be sure to check out Keller's response afterward.)
Honan made a similar argument: Keller, he said, Bactrim schedule, is confusing the medium with the message, and Twitter, like any technology, is what you make it. "If you choose to do superficial things there, you will have superficial experiences. If you use it to communicate with others on a deeper level, you can have more meaningful experiences that make you smarter, Bactrim for sale, build lasting relationships, and generally enhance your life," Honan wrote.
Google gets more local with news Purchase Bactrim, : Google News unveiled a few interesting changes in the past week, starting with the launch of "News near you." Google has sorted news by location for a while now, but this feature will allow smartphone users to automatically get local news wherever they are. ReadWriteWeb's Dan Rowinski explained why newspapers should be worried about Google moving further onto their local-news turf, and GigaOM's Mathew Ingram criticized newspapers for not coming up with like this themselves. Cheap Bactrim, Poynter's Jeff Sonderman, on the other hand, said Google's feature is still in need of some human curation to go with its algorithmic aggregation. That's an area in which local newspapers can still dominate, he said, but it'll require some technological catchup, as well as a willingness to get over fears about linking to competitors, Bactrim over the counter.
Another change, not publicized by Google News but spotted by the folks at Search Engine Land, was the addition of an option to allow users to filter out blogs and press releases from their results. This raised the question, what exactly does Google consider a blog, Purchase Bactrim. Google told Search Engine Land it relies on a variety of factors to make that decision, especially self-identification. Bactrim coupon, Mathew Ingram ripped this classification, and urged Google to put everything that contains news together in Google News and let readers sort it out.
Fitting linking into news' workflow: A discussion about linking has been simmering on Twitter on and off over the past few weeks, and it began to come together into something useful this week. This round of the conversation started with a post by web thinker and scholar Doc Searls, who wondered why news organizations don't link out more often. Purchase Bactrim, In the comments, the Chicago Tribune's Brian Boyer suggested that one reason is that many newspapers' CMS's and workflows are print-centric, making linking logistically difficult.
CUNY j-prof C.W, purchase Bactrim online no prescription. Anderson responded that the workflow issue isn't much of an excuse, saying, as he put it on Twitter: "At this point 'linking' has been around for twenty years. The fact that this is STILL a workflow issue is almost worse than not caring." This kicked off a sprawling debate on Twitter, aptly chronicled via Storify by Mathew Ingram and Alex Byers. Bactrim wiki, Ingram also wrote a post responding to a few of the themes of resistance of links, particularly the notion that information on the web is inferior to information gained by old-fashioned reporting.
British journalist Kevin Anderson took on the workflow issue in particular, noting how outdated many newspaper CMS's are and challenging them to catch up technologically: "It’s an industrial workflow operating in a digital age, Purchase Bactrim. It’s really only down to ‘that’s the way we’ve always done it’ thinking that allows such a patently inefficient process to persist."
AOL's continued makeover: Another week, another slew of personnel moves at AOL. PaidContent's David Kaplan reported that AOL is hiring "a bunch" of new (paid) editors and shuffling some current employees around after its layoff of hundreds this spring. Overall, Kaplan wrote, doses Bactrim work, this is part of the continued effort to put the Huffington Post's stamp on AOL's editorial products.
One of the AOL entities most affected by the shifts is Seed, which had been a freelance network, but will now fall under AOL's advertising area as a business-to-business product. Purchase Bactrim, Saul Hansell, who was hired in 2009 to run Seed, is moving to HuffPo to edit its new "Big News" features. In a blog post, Bactrim long term, Hansell talked about what this means for HuffPo and for Seed.
Meanwhile, the company is also rolling out AOL Industry, a set of B2B sites covering energy, defense, and government. But wait, no prescription Bactrim online, that's not all: AOL's Patch is launching 33 new sites in states targeting the 2012 election. The hyperlocal news site Street Fight also reported that Patch is urging its editors to post more often, and a group of independent local news sites is banding together to tell the world that they are not Patch, nor anything like it.
Reading roundup: As always, plenty of other stuff get to this week, Purchase Bactrim.
— We mentioned a Pew report's reference to the Drudge Report's influence in last week's review, Where can i find Bactrim online, and this week the New York Times' David Carr marveled at Drudge's continued success without many new-media bells and whistles. Poynter's Julie Moos looked at Drudge's traffic over the years, while the Washington Post disputed Pew's numbers. ZDNet's David Gewirtz had five lessons Drudge can teach the rest of the media world.
— A few paid-content items: A Nielsen survey on what people are willing to pay for various mobile services, Poynter's Rick Edmonds on the New York Times' events marketing for its pay plan, and the Lab's Justin Ellis on paid-content lessons from small newspapers, online buying Bactrim hcl. Purchase Bactrim, — A couple of tablet-related items: Next Issue Media, a joint effort of five publishers to sell magazines on tablets, released its first set of magazines on Google Android-powered Samsung Galaxy. And here at the Lab, Ken Doctor expounded on the iPad as the "missing link" in news' digital evolution.
— Columbia University announced it will launch a local news site this summer focusing on accountability journalism, and the Lab's Megan Garber gave some more details about what Columbia's doing with it.
— The Columbia Journalism Review's Lauren Kirchner had an interesting conversation with Slate's David Plotz about Slate's aggregation efforts, and in response, Reuters' Felix Salmon made the case for valuing aggregation skills in journalists.
— This weekend's think piece is a musing by Maria Bustillos at The Awl on Wikipedia, Marshall McLuhan, communal knowledge-making, and the fate of the expert. Enjoy.
Similar posts: Flagyl Cost. Cipro Cost. Bactrim Over The Counter. Online buying Flagyl hcl. Discount Flagyl. Glucophage brand name.
Trackbacks from: Purchase Bactrim. Purchase Bactrim. Purchase Bactrim. Online buy Bactrim without a prescription. Bactrim mg. Bactrim pharmacy.
[This review was originally posted at the Nieman Journalism Lab Diflucan Cost, on May 13, 2011.]
Leaving the old ad model behind: Much of the commentary about digital news this week was generated by two big reports, one on the business of digital journalism and the other on its consumption. We'll start on the business side, with the Columbia j-school's study on what we know so far about the viability of various digital journalism business models. As Poynter's Bill Mitchell suggested, the best entry point into the 146-page report might be the nine recommendations that form its conclusion. Buy Diflucan no prescription, Mitchell summed the report up in three themes: The audience for journalism is growing, though translating that into revenue is a challenge; the old model of banner ads isn't cutting it, and news orgs need to look for new forms of advertising; and news orgs need to play better with aggregators and sharpen their own aggregation skills. In his response to the study, Reuters' Felix Salmon focused on the advertising angle, arguing that journalism and advertising have too long been linked by mere adjacency and that "when you move away from the ad-adjacency model, Diflucan dangers, however, things get a lot more interesting and exciting."
The New York Times' story on the report centered on advertising, too, particularly the growing need for journalists to learn about the business side of their products. (That was media consultant Mark Potts' main takeaway, too.) Emily Bell, a scholar at the center that released the study, said that while journalists need to understand the business of their industry, integrating news and sales staffs isn't necessarily the way to go, Diflucan Cost. Australia, uk, us, usa, The J-Lab's Jan Schaffer recommended that news orgs respond to their business problems by learning from smaller startups and incorporating them more thoroughly into the journalism ecosystem. And paidContent's Staci Kramer advised news orgs to focus on regular audiences rather than fly-by visitors: "Outwardly we like to complain about content farms; in reality, a lot of what news outlets are doing to the side of those front-page stories isn’t very different."
Facebook's growth as news driver: The other major report was released by the Pew Research Center's Project for Excellence in Journalism and looked at how people access news on the web. This study, too, found that despite a small core of frequent users, online Diflucan without a prescription, news sites are dependent on casual users who visit sites infrequently and don't stay long when they're there. Poynter's Rick Edmonds conveniently distilled the study into five big takeaways. Diflucan Cost, The study also found that while Google is still the top referrer to major news sites, Facebook is quickly emerging as a significant news driver, too. University of British Columbia j-prof Alfred Hermida said this lines up with recent research he's done among Canadians, and GigaOM's Mathew Ingram said it showed that while Google is a dominant source for online news now, Diflucan natural, Facebook is primed to succeed it.
Meanwhile, the study also found that surprisingly little traffic to news sites is driven by Twitter. Lauren Dugan of All Twitter said this finding casts some doubt on the idea that Twitter is "a huge link-sharing playground," though the Wall Street Journal's Zach Seward said the study misses that Twitter referrals are undercounted.
The Twitter undercounting was one of several problems that TBD's Steve Buttry had about the study, where can i buy cheapest Diflucan online, including inconsistent language to characterize findings and a bias toward large news organizations. "This study probably has some helpful data, Diflucan Cost. But it has too many huge holes and indications of bias to have much value," Buttry wrote.
Pricing ads and subscriptions on tablets: Condé Nast became the third major magazine publisher to reach an agreement with Apple on app subscriptions, Online buying Diflucan, and one of the first to offer an in-app subscription, with The New Yorker available now. (Wired subscriptions are coming next month.) Time Inc., which reached a deal with Apple last week, clarified that it won't include in-app subscriptions, which would be where Apple takes that now-infamous 30% cut, Diflucan from canada. The Financial Times, meanwhile, is still negotiating with Apple.
Forbes' Jeff Bercovici explained why publishers may be warming to Apple's deal Diflucan Cost, : Turns out, more people are willing to share their personal data with publishers feared. Still, Diflucan online cod, Mathew Ingram of GigaOM used iFlowReader's bad Apple experience as a warning to other companies about the dangers of getting into bed with Apple.
Now that Apple-publisher relations have thawed, the New York Times' David Carr moved to the next issue: Negotiations between publishers and advertisers over how valuable in-app ads are, and how much those ads should cost. Time.com's Chris Gayomali wondered why magazines are more than giving away app subscriptions with print subscriptions, and concluded that it's about getting more eyeballs on the print product, Diflucan overnight, not the app, in order to maintain the all-important ad rate base.
In other words, Carr said in another post, Is Diflucan addictive, publishers are following the old magazine model, where the product is priced below cost and the money is made off advertising instead. He questioned the wisdom of applying that strategy to tablets: "the rich advertising opportunity that will produce may be a less durable and less stable business than grinding out highly profitable circulation over the long haul."
A postmortem on Bin Laden coverage: It's now been close to two weeks since the news of Osama bin Laden's death broke on Twitter, but plenty of folks were still discussing how the story was broken and covered, Diflucan Cost. Gilad Lotan and Devin Gaffney of SocialFlow put together some fascinating visualizations of how the news spread on Twitter, especially the central roles of Donald Rumsfeld staffer Keith Urbahn and New York Times reporter Brian Stelter. Mashable's Chris Taylor concluded from the data that trustworthiness and having active followers (as opposed to just lots of followers) are more important than ever on Twitter.
Media consultant Frederic Filloux was mostly reassured by the way the traditional news outlets handled the story online: "For once, order Diflucan from United States pharmacy, editorial seems to evolve at a faster pace than the business side." There were still folks cautioning against going overboard on Twitter-as-news hype, while the Telegraph's Emma Barnett wondered why pundits are still so surprised at the significant role Twitter and Facebook play in breaking news. ("It's exactly what they were designed for.")
New York Times public editor Arthur Brisbane gave the blow-by-blow of how his paper responded to the story, highlighting a few tweets by Times reporters and editors. Reuters' Felix Salmon chastised Brisbane Diflucan Cost, for not including Brian Stelter's tweets, which were posted a good 15 minutes before the ones he included. Herbal Diflucan, The exclusion, Salmon surmised, might indicate that the Times doesn't see what Stelter did on Twitter as reporting.
Google News founder Krishna Bharat compared the way Google handled 9/11 and Bin Laden's death, marveling at how much more breaking-news coverage is available on the web now. The Lab's Megan Garber used the occasion to glean some insights from Bharat about trusting the authority of the algorithm to provide a rich palette of news, order Diflucan online overnight delivery no prescription, but at Search Engine Land, Danny Sullivan used the Bin Laden coverage to point out some flaws in Google News' algorithm.
Reading roundup: Lots of interesting little rabbit trails to choose from this week. Here are a few:
— ComScore's April traffic numbers are out, and there were a number of storylines flowing out of them: Cable news sources are beating print ones in web traffic, the New York Times' numbers are down (as expected) after implementation of its paywall, and Gawker's numbers are starting to come back after dropping last year with its redesign, Diflucan Cost.
— Last week, Diflucan no rx, ESPN columnist Rick Reilly told graduating students at the University of Colorado's j-school to never write for free. That prompted Jason Fry of the National Sports Journalism Center and Craig Calcaterra of MSNBC.com's Hardball Talk to expound on the virtues of writing for free, though Slate's Tom Scocca took Reilly's side.
— Two thoughtful pieces on brands and journalism: Jason Fry at Poynter on assessing the value of organizational and personal brands, and Vadim Lavrusik at the Lab on journalists building their brands via Facebook.
— Late last week, Google lost an appeal to a 2007 Belgian ruling forcing it to pay newspapers for gaining revenue for linking to their stories on Google News.
— Finally, the Huffington Post's Mandy Jenkins offered a helpful list of 10 ways journalists can use Storify. It's full of great examples and should spark an idea or two.
Similar posts: Buy Cipro No Prescription. Tramadol Price. Zoloft Mg. Cheap Bactrim. Bactrim canada, mexico, india. Buy Bactrim online cod.
Trackbacks from: Diflucan Cost. Diflucan Cost. Diflucan Cost. Diflucan wiki. Buying Diflucan online over the counter. Diflucan coupon.
[This review was originally posted at the Nieman Journalism Lab Buy Glucophage No Prescription, on Nov. 19, 2010.]
An unpopular marriage: As I briefly noted in last week's review, the big story this week was, not surprisingly, Newsweek's merger with Tina Brown and Barry Diller's website The Daily Beast. The New York Observer, which broke the story, buying Glucophage online over the counter, had most of the newsy details — merged websites under The Daily Beast, unspecified layoffs to come, etc. — as well as the story of how the deal went down.
The Daily Beast's own Howard Kurtz had some notes on what the new organization would look like, led by Brown's assertion that whatever the new Newsweek will be, Glucophage recreational, it won't be the newsmagazine format. As The New York Times' Evelyn Rusli observed, the key asset in this deal may not be either property but instead Brown, one of the U.S.' most prominent magazine editors, Buy Glucophage No Prescription. The Wall Street Journal had more notes on Brown, and Slate's Jack Shafer dished out some advice for her.
Just about the only media figure who voiced any sort of excitement about the deal was Arianna Huffington; everyone else's responses ranged from indifference to revulsion. The New York Times' David Carr laid his derision on thick, saying the deal "marries two properties that have almost nothing in common other than the fact that they both lose lots of money." NYU professor Clay Shirky called it a farcical reprise of the AOL-Time Warner bomb. TechCrunch's Erick Schonfeld warned the two companies not to combine their brands (and it appears they won't, except online), Glucophage without prescription.
The Wall Street Journal summed up the doubters' concerns well with a list of four reasons Buy Glucophage No Prescription, for concern: Joint ventures are tough, media joint ventures are tougher, it's headed by strong-willed personalities, and it's a merger of two companies that are losing money. The last point gained the most traction, building on media reports (which Scott Rosenberg questioned) that have Newsweek on pace to lose $20 million this year and The Daily Beast on track to lose $10 million (though it was supposedly expected to turn a profit within two years). Business Insider's Henry Blodget joined the Journal in wondering how they'd make money together, and Forbes' Jeff Bercovici asked a good question: If your media venture is on track to profitability, why would you want to tie yourself to a business that's gone nowhere but down?
There were a couple of possible answers: First, as The New York Times reported, Glucophage price, the Beast's Diller has developed a sudden affinity for print publications. Also, Mediaite's Colby Hall noted that with as much content as the Beast produces, Newsweek's costs could drop pretty quickly, and Advertising Age said advertisers could be attracted by simple novelty of the new organization.
The other big piece of the deal is the fact that it will likely mean the death of Newsweek.com, despite the fact that has a far larger audience than The Daily Beast. The website's staff members are nervously awaiting their fate, but in the meantime took to Tumblr to mount a defense of Newsweek.com, praising its work while saying it has "always remained an ugly stepchild to its print grandparents, who were too busy burning money to notice." Former Newsweek.com staffer Mark Coatney chimed in, wondering what would happen to Newsweek's SEO and content deals without its own site, Buy Glucophage No Prescription. Reuters' Felix Salmon also agreed, purchase Glucophage online, saying the shutdown only makes sense as a power grab by Brown. But Advertising Age and GigaOM defended the move, saying the Beast's traffic is more valuable than Newsweek's.
Don't call it an email killer: Facebook made a big announcement this week, unveiling its new quasi-email, quasi-chat message system, Online buy Glucophage without a prescription, Facebook Messages. (Want to know what it looks like. Search Engine Land has you covered.) The message we heard repeatedly Buy Glucophage No Prescription, from Facebook was that Messages is not a rival to email services like Google's Gmail. And why was that. Well, because it spent most of the weekend being hyped as a "Gmail killer." And the reason it's such a threat to email, said Charlene Li and ReadWriteWeb, is precisely because it's a lot more than email: It's the convergence of chat, email and text messaging; archived communications by friend; and a "social inbox." The gadget blog Gizmodo said we'll be giving up traditional email for it because we're all already using Facebook's interface and because it should be able to sort what's important from what's not, Glucophage no prescription.
But another Gawker blog, Lifehacker, said we shouldn't give up email for Facebook Messages, because it's meant to work with email, not like email. In addition, Glucophage results, anything you say there can't be moved elsewhere. Others were also skeptical, for a variety of reasons: Silicon Alley Insider's Matt Rosoff and the Houston Chronicle Dwight Silverman said this isn't unified communications, but just another way to get hardcore users to spend more time on Facebook, Buy Glucophage No Prescription. GigaOM's Mathew Ingram argued that many people won't use it as an email supplement if it doesn't connect to their existing email accounts. The Guardian talked to an analyst who said Facebook can't handle the task of using all of its data to optimize social messaging. Then there's the privacy issue: Salon's Dan Gillmor said we should be uncomfortable about putting all of our communications into the hands of a single company, especially Facebook.
There were three other thoughtful perspectives on what Facebook Messages means that stood out: Om Malik of GigaOM saw Messages as a critical step for Facebook in helping us stay in touch with our most intimate friends, as opposed to the more distant "second-order" friends it's been specializing in. Buy Glucophage No Prescription, And though he was off about the shape Messages would take, Nick O'Neill of All Facebook aptly placed Messages within a long-running battle between Facebook and Google for online authority.
Finally, buy Glucophage online no prescription, in a post at the Lab, Ken Doctor called for news organizations to embrace the philosophy behind Facebook Messages: "It’s about simplification, about interconnection, about consolidation." Meanwhile, in other much-less-covered email-related news: AOL announced it's relaunching its own email service, a story TechCrunch rather comically broke last Friday. Online buying Glucophage hcl, —
Yahoo goes deeper into original content: Yahoo dived deeper into the original-content pool this week with two moves: First, it added three new blogs to its seven-month-old The Upshot, building a network of originally reported news blogs. The new sites will focus on politics, national news, and media. CNN noted that the new group is being headed by a veteran of Talking Points Memo and quoted Yahoo News head Mark Walker as describing it as Yahoo's biggest original-content push yet: "Pure aggregation will only get you so far, even if you're really good at it."
Yahoo also completed its integration of Associated Content, Glucophage brand name, the content farm it bought in May, by relaunching it as the Yahoo Contributor Network. Through the network, Yahoo plans to post at least 2,000 articles of search engine-friendly content a day, paying its 400,000 contributors a small fee upfront, followed by bonused based on pageviews, Buy Glucophage No Prescription. Kara Swisher of All Things Digital was skeptical of the plan.
Some eye-opening iPad stats: We got a few more pieces of data on iPad use in the past week, including some quick, interesting stats from The Wall Street Journal showing that iPad use jumps in the evening, Effects of Glucophage, while computer use drops. (Smart phone is relatively steady throughout the day.) This seems to correlate with what many have suspected about the iPad — that it's being used as more of a leisure device than phones or computers.
Business Insider had quite a few more fascinating stats from its survey of iPad owners, finding, among other things, that most iPad owners are using their iPads more than when they first got the device, 30% are using it as their primary computer, they're spending as much time with it as they are their laptops, is Glucophage safe, and about equal numbers of people use the browser and apps to read news. Poynter's Damon Kiesow isn't reading much into the data Buy Glucophage No Prescription, , but he did find it surprising that about a third are reading news primarily on apps, considering how few news orgs have them out right now. That's good news for major media outlets, he said, though it doesn't mean much for the little guys.
Meanwhile, News Corp.'s James Murdoch said he thinks news apps for mobile devices like the iPad cannibalize newspaper sales, Glucophage forum, something Reuters' Felix Salmon wasn't sure about, and Poynter's Kiesow wasn't buying without seeing some data. News Corp., by the way, is reported to be close to launching its much-talked-about tablet news publication, and The Economist dropped its own iPad app this week.
Google News' crediting experiment: One cool little story worth highlighting: Google News announced it's introducing two tags for articles that will help indicate which articles were the first to report a story and which articles are essentially the same story on different sites. It's an experiment, as the Lab's Megan Garber noted, in finding out how willing news organizations are to give online credit where credit is due, Buy Glucophage No Prescription. As Search Engine Land's Matt McGee pointed out, ordering Glucophage online, they're based on the honor system, so there's nothing to stop spammers (or legit news organizations) from misusing the tags. CUNY j-prof C.W. Anderson wondered if the tags might provide some new research opportunities for scholars.
Reading roundup: Here's everything else worth taking a look at before you hit the weekend:
— Over at the National Sports Journalism Center, Jason Fry has written a wonderful column on the importance of the link to sports journalism, and it goes for all journalism as well. Buy Glucophage No Prescription, Elsewhere, Terry Heaton wrote about the value of the link in online advertising, a notion The Batavian's Howard Owens took issue with.
— A few paid-content tidbits: Connecticut's Valley Independent Sentinel is the latest local newspaper to make use of Journalism Online's Press+ paid-content system, The Times of London is partnering with a mobile broadband provider for a free-access offer at its website, and two new-media companies are working on an online news "EZ Pass."
— A couple pieces from last week I missed: Mashable's Vadim Lavrusik and Eastern Illinois j-prof Bryan Murley both urged j-schools to push some more boundaries in their teaching of news and technology.
— Weekly fuel for the pessimists among us: Poynter's Rick Edmonds on the signs that newspapers are still failing financially, and the nonprofit news site The Washington Independent announced it's closing up shop.
— And in the food-for-thought category: Jonathan Stray on the real value of social news, and CUNY j-prof C.W. Anderson at the Lab on journalism and online community. "We can’t will authentic community into being. It sort of sneaks up on us. And just as quickly — as soon as we turn our heads — it’s gone.".
Similar posts: Synthroid Cost. Lipitor No Rx. Purchase Retin A. Glucophage from canadian pharmacy. Where can i buy cheapest Flagyl online. Glucophage photos.
Trackbacks from: Buy Glucophage No Prescription. Buy Glucophage No Prescription. Buy Glucophage No Prescription. Is Glucophage safe. Glucophage coupon. Purchase Glucophage online no prescription.